Monday, 28 July 2014

Global Single Nucleotide Polymorphism Genotyping and Analysis Market to Grow at a 20.65% CAGR by 2018



Single Nucleotide Polymorphism (SNP) genotyping is the screening and analysis of genetic variations of SNPs in the genome of various species. SNPs are commonly present in all species including humans. SNP genotyping and analysis technology can analyze thousands of SNPs and has the potential for whole-genome genotyping. It is the most common genetic variation that occurs in the genetic makeup. It is an emerging field in life science, which provides an in-depth analysis of SNPs. It is generally used by researchers for genomics study. It has a broad range of applications in several industries such as Pharmaceuticals and Pharmacogenomics, Diagnostics Research, Agriculture Biotechnology, and Breeding and Animal Livestock. There are several technologies which are used for SNP genotyping and analysis such as SNP GeneChips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex, and MassARRAY Matrix-assisted Laser Desorption/Ionization-Time-of-Flight.

Analysts forecast the Global SNP Genotyping and Analysis market to grow at a CAGR of 20.65 percent over the period 2013-2018.

Pharmacogenomics involves the study of genetic variations that influence an individual's response to drugs. It is one of the crucial steps of personalized treatment. It has many applications in clinical practices, including the detection of viral drug resistance, targeted therapy, and the minimization of the adverse effects of drugs. The FDA also encourages the use of pharmacogenomics for the drug development process. Pharmacogenomics is a major step in clinical trials to study the toxicity and side effects of the drug.


Covered in this Report
This report covers the present scenario and the growth prospects of the Global SNP Genotyping and Analysis market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of SNP analysis systems, consumables, and services used in SNP analysis. In addition, predominant technologies used for SNP genotyping and analysis, such as SNP gene chips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex and MassARRAY Matrix-assisted Laser Desorption/Ionization-Time-of-Flight, are considered in the scope of the report.

Global SNP Genotyping and Analysis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global SNP Genotyping and Analysis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, the Global SNP Genotyping and Analysis market is driven by several factors. Advancement in SNP genotyping and analysis technology is one of the major drivers. The improved accuracy, high sensitivity, and better diagnostic speed of SNP genotyping tools drive the growth of the Global SNP Genotyping and Analysis market.

Further, the report states that though the market has several drivers, the growth of the Global SNP Genotyping and Analysis market is curtailed by certain challenges. One of the major challenges is the reimbursement complications for new technologies including SNP genotyping tools. The existing policies usually do not cover new technologies.